Breast Health · news
Latest Breast Health news
511 reports · newest first
- Breast Health News
Doctor With Breast Cancer Will Be Air-Lifted From South Pole (dateline October 6, 1999)
Two LC-130 Air National Guard cargo planes equipped with ski landing gear left Scotia, New York on Wednesday to rescue Dr. Jerri Nielsen, a medical doctor on the United States Amundsen-Scott South Pole Research Station in Antarctica who has breast cancer.
- Breast Health News
FDA Approves ELLENCE, A New Breast Cancer Treatment (dateline September 16, 1999)
Data shows ELLENCE reduces risk of death and cancer recurrence in women with early breast cancer; could save thousands of lives each year. Pharmacia & Upjohn today announced that the U.S.
- Breast Health News
New Research Sheds Light On Why Women Build Resistance To Tamoxifen Breast Cancer Therapy (dateline July 30, 1999)
Breast cancer patients taking the drug tamoxifen (trade name Novaldex) generally develop resistance to the drug two to five years into treatment.
- Breast Health News
New guidelines help doctors determine which women should be offered tamoxifen to prevent breast cancer (dateline May 18, 1999)
How do women determine if they are at risk for breast cancer? ASCO recommendations are disputed by some Role of raloxifene in preventing breast cancer Summary conclusion from the ASCO Report Additional information and references Study of tamoxifen and raloxifene (STAR) trial A new study suggests tha
- Breast Health News
New FDA Mammography Act Requires Facilities to Provide Written Results to Patients within 30 days (dateline May 3, 1999)
As of April 28, 1999, all women who have mammograms must be informed of the results in writing, under the U.S. Food and Drug Administration (FDA) Mammography Quality Standards Reauthorization Act of 1998.
- Breast Health News
New FDA Mammography Act Requires Facilities to Provide Written Results to Patients within 30 days (dateline April 28, 1999)
As of April 28, 1999, all women who have mammograms must be informed of the results in writing, under the U.S. Food and Drug Administration (FDA) Mammography Quality Standards Reauthorization Act of 1998.
- Breast Health News
Duke University Study Renews Hope For Use of Angiostatin to Shrink Cancer Tumors (dateline March 16, 1999)
Angiostatin and endostatin have been among the most exciting items in cancer research over the past year. These drugs shrink cancer tumors to the size of a pinhead by choking off the blood supply to the tumors. But despite optimistic media attention there have been some major obstacles.